Allison A. Dilliott

ORCID: 0000-0003-3863-9304
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Amyotrophic Lateral Sclerosis Research
  • Genomics and Rare Diseases
  • Neurogenetic and Muscular Disorders Research
  • Alzheimer's disease research and treatments
  • Dementia and Cognitive Impairment Research
  • Neurological diseases and metabolism
  • RNA Research and Splicing
  • Traumatic Brain Injury and Neurovascular Disturbances
  • Cerebral Palsy and Movement Disorders
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Cerebrovascular and genetic disorders
  • Cerebrospinal fluid and hydrocephalus
  • Stroke Rehabilitation and Recovery
  • Parkinson's Disease Mechanisms and Treatments
  • Acute Ischemic Stroke Management
  • Bioinformatics and Genomic Networks
  • RNA modifications and cancer
  • Epigenetics and DNA Methylation
  • BRCA gene mutations in cancer
  • Congenital Ear and Nasal Anomalies
  • Genetics and Neurodevelopmental Disorders
  • Balance, Gait, and Falls Prevention
  • Neurological Disease Mechanisms and Treatments
  • Lipid metabolism and disorders
  • Eicosanoids and Hypertension Pharmacology

Montreal Neurological Institute and Hospital
2022-2025

McGill University
2022-2025

Health Sciences Centre
2024

Sunnybrook Health Science Centre
2024

Western University
2015-2023

Robarts Clinical Trials
2018-2023

Novartis (Canada)
2019

Montreal Heart Institute
2016

Université de Montréal
2016

Objective— Next-generation sequencing technology is transforming our understanding of heterozygous familial hypercholesterolemia, including revision prevalence estimates and attribution polygenic effects. Here, we examined the contributions monogenic factors in patients with severe hypercholesterolemia referred to a specialty clinic. Approach Results— We applied targeted next-generation custom annotation, coupled evaluation large-scale copy number variation scores for raised low-density...

10.1161/atvbaha.116.308027 article EN Arteriosclerosis Thrombosis and Vascular Biology 2016-10-21

Amyotrophic lateral sclerosis (ALS) is a complex disease that leads to motor neuron death. Despite heritability estimates of 52%, genome-wide association studies (GWASs) have discovered relatively few loci. We developed machine learning approach called RefMap, which integrates functional genomics with GWAS summary statistics for gene discovery. With transcriptomic and epigenetic profiling neurons derived from induced pluripotent stem cells (iPSCs), RefMap identified 690 ALS-associated genes...

10.1016/j.neuron.2021.12.019 article EN cc-by-nc-nd Neuron 2022-01-18

Background Despite several studies suggesting a potential oligogenic risk model in amyotrophic lateral sclerosis (ALS), case–control statistical evidence implicating oligogenicity with disease or clinical outcomes is limited. Considering its direct and therapeutic implications, we aim to perform large-scale robust investigation of ALS the course. Methods We leveraged Project MinE genome sequencing datasets (6711 cases 2391 controls) identify associations between known genes risk, as well...

10.1136/jnnp-2024-335364 article EN cc-by Journal of Neurology Neurosurgery & Psychiatry 2025-02-13

Plasma biomarkers of Alzheimer disease (AD), neuroinflammation, and neurodegeneration are increasingly being used in clinical trials for diagnosis monitoring dementia. However, their association with longitudinal structural brain MRI changes, an important outcome measure across neurodegenerative cerebrovascular diseases, is less known. We investigated how baseline plasma reflect markers progression over time patients diseases. This cohort study included from the Ontario Neurodegenerative...

10.1212/wnl.0000000000213438 article EN Neurology 2025-03-10
Heidi C. Riek Donald C. Brien Brian C. Coe Jeff Huang Julia E. Perkins and 89 more Rachel Yep Paula McLaughlin J. B. Orange Alicia Peltsch Angela Roberts Malcolm A. Binns Wendy Lou Agessandro Abrahão Stephen R. Arnott Derek Beaton Sandra E. Black Dar Dowlatshahi Elizabeth Finger Corinne E. Fischer Andrew Frank David A. Grimes Sanjeev Kumar Anthony E. Lang Jane M. Lawrence‐Dewar Jennifer Mandzia Connie Marras Mario Masellis Stephen Pasternak Bruce G. Pollock Tarek K. Rajji Demetrios J. Sahlas Gustavo Saposnik Dallas Seitz Christen Shoesmith Thomas Steeves Stephen C. Strother Kelly M. Sunderland Richard H. Swartz Brian Tan David F. Tang‐Wai Maria Carmela Tartaglia John Turnbull Lorne Zinman Douglas P. Munoz Sabrina Adamo Robert Bartha Courtney Berezuk Alanna Black Michael Borrie Susan E. Bronskill Dennis E. Bulman Leanne K. Casaubon Ben Cornish Sherif Defrawy Allison A. Dilliott Roger A. Dixon Sali M.K. Farhan Frederico Faria Julia Fraser Morris Freedman Mahdi Ghani Barry Greenberg Hassan Haddad Ayman Hassan Wendy Hatch Rob Hegele Melissa F. Holmes Chris Hudson Mandar Jog Peter Kleinstiver Donna Kwan Elena Leontieva Brian Levine Efrem D. Mandelcorn Ed Margolin Bill McIlroy Manuel Montero‐Odasso David G. Munoz Nuwan D. Nanayakkara Miracle Ozzoude Joel Ramirez Natalie Rashkovan John F. Robinson Ekaterina Rogaeva Yanina Sarquis Adamson Christopher J.M. Scott Michael J. Strong Sujeevini Sujanthan Sean Symons Athena Theyers Angela K. Troyer Karen Van Ooteghem John Woulfe Mojdeh Zamyadi

Abstract Oculomotor tasks generate a potential wealth of behavioural biomarkers for neurodegenerative diseases. Overlap between oculomotor and disease-impaired circuitry reveals the location severity disease processes via saccade parameters measured from eye movement such as prosaccade antisaccade. Existing studies typically examine few in single diseases, using multiple separate neuropsychological test scores to relate behaviour cognition; however, this approach produces inconsistent,...

10.1093/braincomms/fcad049 article EN cc-by Brain Communications 2023-03-02

Abstract INTRODUCTION We investigated whether novel plasma biomarkers are associated with cognition, cognitive decline, and functional independence in activities of daily living across within neurodegenerative diseases. METHODS Glial fibrillary acidic protein (GFAP), neurofilament light chain (NfL), phosphorylated tau (p‐tau)181 amyloid beta (Aβ) 42/40 were measured using ultra‐sensitive Simoa immunoassays 44 healthy controls 480 participants diagnosed Alzheimer's disease/mild impairment...

10.1002/alz.13560 article EN cc-by Alzheimer s & Dementia 2023-12-17

Abstract INTRODUCTION Apolipoprotein E E4 allele ( APOE E4) and slow gait are independently associated with cognitive impairment dementia. However, it is unknown whether their coexistence poorer performance its underlying mechanism in neurodegenerative diseases. METHODS Gait speed, E4, cognition, neuroimaging were assessed 480 older adults neurodegeneration. Participants grouped by presence gait. Mediation analyses conducted to determine if brain structures could explain the link between...

10.1002/alz.13740 article EN cc-by-nc Alzheimer s & Dementia 2024-03-12

Abstract Introduction/Aims Genetics is an important risk factor for amyotrophic lateral sclerosis (ALS), a neurodegenerative disease affecting motor neurons. Recent findings demonstrate that in addition to specific genetic mutations, structural variants caused by instability can also play causative role ALS. Genomic lead deletions, duplications, insertions, inversions, and translocations the genome, these changes sometimes fusion of distinct genes into single transcript. Gene events have...

10.1002/mus.28043 article EN Muscle & Nerve 2024-02-02

Next-generation sequencing (NGS) is quickly revolutionizing how research into the genetic determinants of constitutional disease performed. The technique highly efficient with millions reads being produced in a short time span and at relatively low cost. Specifically, targeted NGS able to focus investigations genomic regions particular interest based on study. Not only does this further reduce costs increase speed process, but it lessens computational burden that often accompanies NGS....

10.3791/57266 article EN Journal of Visualized Experiments 2018-04-04

Abstract Introduction Understanding synergies between neurodegenerative and cerebrovascular pathologies that modify dementia presentation represents an important knowledge gap. Methods This multi‐site, longitudinal, observational cohort study recruited participants across prevalent diseases disease assessed comprehensively modalities. We describe univariate multivariate baseline features of the summarize recruitment, data collection, curation processes. Results enrolled 520 five diseases....

10.1002/alz.12632 article EN Alzheimer s & Dementia 2022-03-30

Abstract The Ontario Neurodegenerative Disease Research Initiative (ONDRI) is a multimodal, multi-year, prospective observational cohort study to characterise five diseases: (1) Alzheimer’s disease (AD) or amnestic single multidomain mild cognitive impairment (aMCI) (AD/MCI); (2) amyotrophic lateral sclerosis (ALS); (3) frontotemporal dementia (FTD); (4) Parkinson’s (PD); and (5) vascular (VCI). ONDRI Genomics subgroup investigating the genetic basis of neurodegeneration. We have developed...

10.1038/npjgenmed.2016.32 article EN cc-by npj Genomic Medicine 2016-09-21

Objective: Genetic determinants of severe hypertriglyceridemia include both common variants with small effects (assessed using polygenic risk scores) plus heterozygous and homozygous rare in canonical genes directly affecting triglyceride metabolism. Here, we broadened our scope to detect associations loss-of-function noncanonical pathways, including those known affect metabolism indirectly. Approach Results: From targeted next-generation sequencing 69 metabolism-related 265 patients...

10.1161/atvbaha.120.314168 article EN Arteriosclerosis Thrombosis and Vascular Biology 2020-06-25

Genetic factors contribute to neurodegenerative diseases, with high heritability estimates across diagnoses; however, a large portion of the genetic influence remains poorly understood. Many previous studies have attempted fill gaps by performing linkage analyses and association in individual disease cohorts, but failed consider clinical pathological overlap observed diseases potential for between phenotypes. Here, we leveraged rare variant (RVAAs) elucidate among multiple diagnoses,...

10.1038/s41525-021-00243-3 article EN cc-by npj Genomic Medicine 2021-09-28

White matter hyperintensities (WMH) on magnetic resonance imaging may influence clinical presentation in patients with Parkinson's disease (PD), although their significance and pathophysiological origins remain unresolved. Studies examining WMH have identified pathogenic variants NOTCH3 as an underlying cause of inherited forms cerebral small vessel disease.We examined variants, volumes, correlates 139 PD the Ontario Neurodegenerative Disease Research Initiative cohort.We 13 (~9%) rare (<1%...

10.1002/mds.28171 article EN Movement Disorders 2020-06-23

Abstract Multiplexing samples from distinct individuals prior to sequencing is a promising step toward achieving population-scale single-cell RNA by reducing the restrictive costs of technology. Individual genetic demultiplexing tools resolve donor-of-origin identity pooled cells using natural variation but present diminished accuracy on highly multiplexed experiments, impeding analytic potential dataset. In response, we introduce Ensemblex: an accuracy-weighted, ensemble framework that...

10.1101/2024.06.17.599314 preprint EN cc-by bioRxiv (Cold Spring Harbor Laboratory) 2024-06-19
Di Yu Nuanyi Liang Julia Zebarth Qing Shen Miracle Ozzoude and 95 more Maged Goubran Jennifer S. Rabin Joel Ramirez Christopher J.M. Scott Fuqiang Gao Robert Bartha Sean Symons Seyyed Mohammad Hassan Haddad Courtney Berezuk Brian Tan Donna Kwan Robert A. Hegele Allison A. Dilliott Nuwan D. Nanayakkara Malcolm A. Binns Derek Beaton Stephen R. Arnott Jane M. Lawrence‐Dewar Ayman Hassan Dar Dowlatshahi Jennifer Mandzia Demetrios J. Sahlas Leanne K. Casaubon Gustavo Saposnik Yurika Otoki Krista L. Lanctôt Mario Masellis Sandra E. Black Richard H. Swartz Ameer Y. Taha Walter Swardfager Natalie Rashkovan Sandra E. Black Agessandro Abrahão Lorne Zinman Alisia Bonnick Richard H. Swartz Mario Masellis Joel Ramirez Christopher J.M. Scott Sean Symons Courtney Berezuk Melissa F. Holmes Sabrina Adamo Miracle Ozzoude Morris Freedman Brian Tan Mojdeh Zamyadi Stephen R. Arnott Derek Beaton Malcolm A. Binns Pradeep Reddy Raamana Stephen C. Strother Kelly M. Sunderland Athena Theyers Abiramy Uthirakumaran Brian Levine Angela K. Troyer Michael J. Strong Peter Kleinstiver Michael Borrie Elizabeth Finger Christen Shoesmith Frederico Faria Manuel Montero‐Odasso Yanina Sarquis‐Adamson Alanna Black Jennifer Mandzia Allison A. Dilliott Rob Hegele John F. Robinson Sali M.K. Farhan Robert Bartha Hassan Haddad Nuwan D. Nanayakkara Guangyong Zou Stephen Pasternak J. B. Orange Angela Roberts Mandar Jog Dallas Seitz Don Brien Ying Chen Brian C. Coe Doug Munoz Paula McLaughlin Alicia Peltsch Donna Kwan Susan E. Bronskill Wendy Lou Sanjeev Kumar Bruce G. Pollock Tarek K. Rajji David F. Tang‐Wai Maria Carmela Tartaglia

Background Cerebral small vessel disease is associated with higher ratios of soluble-epoxide hydrolase derived linoleic acid diols (12,13-dihydroxyoctadecenoic [DiHOME] and 9,10-DiHOME) to their parent epoxides (12(13)-epoxyoctadecenoic [EpOME] 9(10)-EpOME); however, the relationship has not yet been examined in stroke. Methods Results Participants mild moderate stroke or large were selected based on clinical imaging criteria. Metabolites quantified by ultra-high-performance liquid...

10.1161/jaha.122.026901 article EN cc-by-nc-nd Journal of the American Heart Association 2022-12-30

Acute change in gait speed while performing a mental task [dual-task cost (DTC)], and hyperintensity magnetic resonance imaging signals white matter are both important disability predictors older individuals with history of stroke (poststroke). It is still unclear, however, whether DTC associated overall volume from specific major brain regions poststroke.This cohort study total 123 (69 ± 7 years age) participants were included the Ontario Neurodegenerative Disease Research Initiative....

10.1177/15459683231177606 article EN cc-by Neurorehabilitation and neural repair 2023-06-02

Choanal atresia is rarely reported in Kabuki syndrome, but a common feature of CHARGE syndrome. Otherwise, the two conditions have number overlapping features, and molecular links between them recently been elucidated. Here, we report case mother her children who presented with congenital choanal atresia. We performed whole exome sequencing on DNA from unaffected parents, identified de novo, novel variant KMT2D. KMT2D p.Gln3575His segregated disease status family, associated unique conserved...

10.1002/ajmg.a.38010 article EN American Journal of Medical Genetics Part A 2016-11-07
Joel Ramirez Melissa F. Holmes Courtney Berezuk Donna Kwan Brian Tan and 95 more Derek Beaton Christopher J.M. Scott Miracle Ozzoude Fuqiang Gao Di Yu Walter Swardfager Jane M. Lawrence‐Dewar Dar Dowlatshahi Gustavo Saposnik Mark I. Boulos Brian J. Murray Sean Symons Robert Bartha Sandra E. Black Richard H. Swartz Andrew Lim Michael J. Strong Peter Kleinstiver Natalie Rashkovan Susan E. Bronskill Sandra E. Black Michael Borrie Elizabeth Finger Corinne E. Fischer Andrew Frank Morris Freedman Sanjeev Kumar Stephen Pasternak Bruce G. Pollock Tarek K. Rajji Dallas Seitz David F. Tang‐Wai Maria Carmela Tartaglia Brenda Varriano Agessandro Abrahão Marvin Chum Christen Shoesmith John Turnbull Lorne Zinman Jane M. Lawrence‐Dewar Donna Kwan Brian Tan Julia Fraser Bill McIlroy Ben Cornish Karen Van Ooteghem Frederico Faria Manuel Montero‐Odasso Yanina Sarquis‐Adamson Alanna Black Barry Greenberg Wendy Hatch Chris Hudson Elena Leontieva Ed Margolin Efrem D. Mandelcorn Faryan Tayyari Sherif Defrawy Don Brien Ying Chen Brian C. Coe Doug Munoz Alisia Bonnick Leanne K. Casaubon Dar Dowlatshahi Ayman Hassan Jennifer Mandzia Demetrios J. Sahlas Gustavo Saposnik Richard H. Swartz David P. Breen David A. Grimes Mandar Jog Anthony E. Lang Connie Marras Mario Masellis Tom Steeves Dennis E. Bulman Allison A. Dilliott Mahdi Ghani Rob Hegele John F. Robinson Ekaterina Rogaeva Sali M.K. Farhan Robert Bartha Hassan Haddad Nuwan D. Nanayakkara Joel Ramirez Christopher J.M. Scott Sean Symons Courtney Berezuk Melissa F. Holmes Sabrina Adamo Miracle Ozzoude Mojdeh Zamyadi

10.1016/j.sleep.2021.03.043 article EN publisher-specific-oa Sleep Medicine 2021-04-20
Coming Soon ...